Search results
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 3 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float for NVAX is 132.98M ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
InvestorPlace· 17 hours agoIf you have a high tolerance for volatility then the biotech sector might be for you. Biotech stocks...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 5 days agoThat could happen if Amtagvi sales truly take off, showing the potential of TIL technology. But even...
12 Most Shorted Stocks in 2024
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will take a detailed look at the 12 Most Shorted Stocks in 2024. For a quick overview of such stocks, read our article 5 Most Shorted...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Zacks via Yahoo Finance· 4 days agoLNTH is just one of a large group of Medical stocks with a positive ESP figure. Novavax (NVAX) is...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 3 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
What's in Store for Biogen (BIIB) This Earnings Season?
Zacks via Yahoo Finance· 7 days agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...